- Glenview Capital Management’s 13F portfolio value increased from $4.51B to $4.56B this quarter. The number of positions increased from 53 to 54.
- They added to their large short position in SPY through Puts while increasing Alight, Corteva, Myriad Genetics, and Brookdale Senior Living.
- The top three stakes are SPDR S&P 500 Index ETF Puts, Cigna, and Tenet Healthcare. They add up to ~31% of the portfolio.
This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 5/15/2023. Please visit our Tracking Larry Robbins’ Glenview Capital Management Portfolio article for an idea on his investment philosophy and our previous update for the fund’s moves during Q4 2022.
This quarter, Robbins’ 13F portfolio value increased from
$4.51B to $4.56B. The number of holdings increased from 53 to 54. There are 35
positions that are significantly large. The focus of this article is on these
larger positions. The top five stakes are SPDR S&P 500 Index ETF Puts,
Cigna, Tenet Healthcare, Fiserv, and Global Payments. Together they are at ~42%
of the 13F assets.
The spreadsheet below highlights changes to Robbins’ 13F
stock holdings in Q1 2023:
Source: John Vincent. Data constructed from Glenview Capital
Management’s 13F filings for Q4 2022 and Q1 2023.
No comments :
Post a Comment